StoneX Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236K Hold
3,650
0.01% 676
2025
Q4
$246K Buy
3,650
+132
+4% +$8.88K 0.01% 786
2025
Q3
$258K Buy
+3,518
New +$234K 0.01% 744
2025
Q2
Sell
-4,339
Closed -$277K 947
2025
Q1
$277K Buy
+4,339
New +$252K 0.02% 670

Other funds holding HALO

StoneX Group's HALO Position: Q1 2026 in Review

StoneX Group held its Halozyme (HALO) position steady in Q1 2026 at 3,650 shares worth $236K. The position accounts for 0.01% of the portfolio, ranked #676.

StoneX Group first reported a position in HALO in Q1 2025 and has held it in 4 quarters since. The position peaked at $277K in Q1 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • StoneX Group held 3,650 shares of Halozyme worth $236K as of Q1 2026.
  • StoneX Group left its Halozyme share count unchanged in Q1 2026.
  • Halozyme made up 0.01% of StoneX Group's portfolio in Q1 2026, its #676 holding.
  • StoneX Group first reported a position in Halozyme in Q1 2025 and has held it in 4 quarters since.
  • StoneX Group's Halozyme position peaked at $277K in Q1 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.